Bond.az - Jupiter Neurosciences (NASDAQ: JUNS) reported first quarter EPS of $-0.06, worse than the analyst estimate of $-0.05. Revenue for the quarter came in at $18.65K versus the consensus estimate of $225K.
The company's stock price closed at $0.23. It is down -56.60% in the last 3 months and down -71.95% in the last 12 months.
Jupiter Neurosciences saw positive and negative EPS revisions in the last 90 days.
According to Bond.az, the company's Financial Health score is "weak performance".











